Aviado · Research
Longevity Daily
Friday, July 10, 2026
Listen
Today's Brief
The biggest clinical story this week is a high-profile setback: the Phase 3 EVOKE trial of semaglutide for Alzheimer's produced disappointing results despite real-world data from over a million patients suggesting 40–70% risk reduction — a gap longevity researchers will be unpacking for years. UCSF and Samsung push forward with a 1,000-person remote cognitive aging study, while Nature Medicine publishes a landmark review on biological aging clocks. Elsewhere, UCLA finds creatine may supercharge cancer-fighting immune cells, and a sweeping new synthesis makes the case that autophagy is the shared mechanism behind every validated longevity intervention.
10 stories5 peer-reviewed2 trials1 Aviado original
Cognitive Health & Neuroprotection
Semaglutide Fails Phase 3 Alzheimer's Trial Despite Striking Real-World Evidence
The EVOKE trial — one of the most comprehensively designed Alzheimer's studies in years, with MRI, cerebrospinal fluid biomarkers, and cognitive composites across a long treatment duration — found that semaglutide did not meaningfully slow disease progression, a result conference presenters described as "disappointing." The sting is compounded by earlier observational data: a target trial emulation of over 1 million patients with type 2 diabetes had shown a 40–70% lower risk of first-time Alzheimer's diagnosis with semaglutide versus other antidiabetic drugs. If you're taking a GLP-1 agonist hoping for brain protection, this Phase 3 result suggests that treating established Alzheimer's is a different — and harder — proposition than observational data implied. Whether semaglutide could work as a prevention tool in earlier, healthier populations remains an open and important question.
Read more →UCSF and Samsung Launch 1,000-Person Remote Trial to Map Cognitive Aging in Real Time
The TAH-DA study, a partnership between UCSF Neuroscape and Samsung, enrolls 1,000 adults to longitudinally track cognitive decline across the adult lifespan using consumer wearables — making it one of the largest and most ecologically valid brain aging studies ever attempted. Unlike lab-based trials, it captures how cognition actually shifts in real-world conditions, with the goal of identifying early predictors of decline before symptoms emerge. The data it generates could transform how we personalize brain health interventions and define what "normal" cognitive aging actually looks like.
Read more →Online Brain Training Measurably Improves Cognitive Health Across All Ages, Study Finds
A study published in Scientific Reports found that adults of all ages — not just younger cohorts — showed measurable improvements in brain health after using accessible online cognitive training and coaching tools over a multi-year period, suggesting the aging brain retains meaningful plasticity well into later life. The finding matters because most brain health intervention trials skew toward younger or middle-aged participants; this study extends the evidence base to older adults. Consistent cognitive engagement through accessible, remote tools may offer a practical, low-cost path to maintaining resilience against age-related decline.
Read more →Supplements & Compounds
The Omega-3 Brain Paradox: Higher Blood Levels Help, But Supplements May Not Close the Gap
A New York Times deep-dive confirms that people with higher omega-3 levels in their blood consistently show better cognition and lower dementia risk — but finds the case for fish oil supplements specifically is shakier than most buyers assume. Absorption rates vary widely, most supplement trials use lower doses than the dietary patterns that show benefit, and the EPA-to-DHA ratio may matter in ways most products ignore. If you eat fatty fish regularly, you may already be capturing the bulk of the benefit; if not, supplements are worth discussing with your doctor — but don't expect the same results as a genuinely high-omega-3 diet.
Read more →UCLA Study: Creatine May Supercharge Immune Cells That Detect and Destroy Cancer
Researchers at UCLA found that creatine enhances the activity of certain immune cells responsible for detecting and attacking cancer — a mechanism entirely separate from its well-known effects on muscle strength and recovery. The research is early-stage and has not yet been tested in human cancer patients, so it shouldn't change your supplement strategy for cancer prevention. But for those already taking creatine for muscle or cognitive benefits, this adds to a growing body of evidence that the compound's biological reach extends well beyond the gym.
Read more →Research & Papers
Nature Medicine Reviews Biological Aging Clocks — and Where the Science Actually Stands
A landmark review in Nature Medicine maps the current landscape of biological clocks — DNA methylation assays, proteomics panels, and other tools attempting to measure your body's true rate of aging — and critically assesses how close they are to clinical usefulness. The authors see genuine promise: clocks can already identify individuals at elevated disease risk and track whether lifestyle or pharmacological interventions are shifting the aging trajectory. Key caveat: most clocks are validated at the population level, and the jump from a biological age readout to an individual clinical recommendation remains a substantial work in progress.
Read more →Autophagy May Be the Common Thread Linking Every Proven Longevity Intervention
A new synthesis review makes a provocative case that autophagy — the cellular housekeeping process that degrades and recycles damaged proteins and organelles — is the shared mechanism behind virtually every validated longevity intervention: caloric restriction, exercise, sleep, sauna, cold exposure, and drugs like rapamycin, metformin, spermidine, and urolithin A. In simple organisms, disabling autophagy genes eliminates the lifespan benefits of these interventions entirely — strong causal evidence from model systems. The practical implication: time-restricted eating, consistent exercise, and several supplements already in heavy rotation among longevity enthusiasts may be working in part through this common biological thread.
Read more →Aviado Research: Evidence Review in Longevity Science
This week's Aviado Research feature provides an evidence-based review of current findings in longevity science, cutting through the noise to surface what the literature actually supports. Read the full analysis for in-depth conclusions and practical takeaways designed for health-optimizing readers.
Read the full Aviado analysis →Lifestyle & Nutrition
A Longevity Doctor's Reality Check: Bryan Johnson's Diagnosis Proves You Can't Biohack Genetics
When Bryan Johnson — who reportedly spends $2 million a year optimizing his biology — was diagnosed with autoimmune gastritis, a condition no protocol can prevent, a practicing longevity physician took to Outside Online to offer grounded perspective: genetics set floors and ceilings that no amount of supplementation, tracking, or testing can fully override. The doctor's message is refreshingly practical — sleep, movement, a nutrient-rich diet, and meaningful social connection do more for most people than extreme interventions. It's a useful corrective in a culture that increasingly confuses optimization with invincibility.
Read more →Your Gut Microbiome May Influence Brain and Muscle Aging More Than You Realize
A review from Fight Aging! synthesizes emerging evidence that the composition of the gut microbiome influences aging in both skeletal muscle and the brain — potentially as powerfully as diet or exercise in animal models. Restoring a younger-profile microbial balance in aged animals has been shown to improve physical and cognitive function and extend lifespan in multiple species. The practical upshot: the dietary fiber, fermented foods, and lifestyle habits you're already optimizing are likely working partly through the gut-aging axis, adding another reason to keep them front and center.
Read more →